文献速递流行病学与生物统计临床试验与 GCP

脊柱手法治疗慢性下背痛的获益与危害:随机对照试验的系统综述与Meta分析

Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials.
PubMed 文献 · BMJ · 2019-03-13

该系统综述与Meta分析纳入47项随机对照试验共9211名平均中年(35-60岁)的慢性下背痛患者,比较脊柱手法治疗与推荐疗法、非推荐疗法、假手法及辅助治疗的效果。中等质量证据提示脊柱手法治疗在短期疼痛缓解上与推荐疗法效果相似,在功能上有小的临床更好改善;高质量证据提示其功能改善优于非推荐疗法。约一半研究评估了不良事件,多为肌肉骨骼相关、一过性、轻至中度。

要点

  • 中等质量证据:脊柱手法治疗短期疼痛缓解与推荐疗法相似,功能有小的临床更好改善。
  • 高质量证据:脊柱手法治疗短期功能改善优于非推荐疗法,但疼痛改善无临床优势。
  • 假手法证据质量低至极低,效应不确定;不良事件多为肌肉骨骼相关、一过性、轻至中度。

核心结论

  • 脊柱手法治疗对慢性下背痛的效果与推荐疗法相似,短期功能改善可能优于非推荐干预。
  • 临床医生应告知患者脊柱手法治疗相关的潜在不良事件风险。

研究设计与样本

  • 随机对照试验的系统综述与Meta分析,检索Medline、PubMed、Embase、Cochrane CENTRAL、CINAHL、PEDro、Index to Chiropractic Literature及试验注册库至2018年5月4日。
  • 纳入47项随机对照试验共9211名平均中年(35-60岁)的慢性下背痛成人患者,排除仅研究坐骨神经痛的研究及灰色文献,无语言或环境限制。
  • 两名评价者独立筛选研究、提取数据并评估偏倚风险与证据质量,采用GRADE评估证据质量,使用随机效应模型并探索统计异质性。

主要发现

  • 与推荐疗法相比,中等质量证据显示脊柱手法治疗短期疼痛缓解相似(均数差-3.17,95%CI -7.85至1.51),功能有小的临床更好改善(SMD -0.25,95%CI -0.41至-0.09)。
  • 与非推荐疗法相比,高质量证据显示脊柱手法治疗短期疼痛缓解有小的、无临床更好的效果(均数差-7.48,95%CI -11.50至-3.47),功能有小的至中等临床更好改善(SMD -0.41,95%CI -0.67至-0.15)。
  • 中期和长期结局及作为辅助治疗的效果与上述结果总体相似。
  • 一项低选择偏倚风险、以评估风险为把握度的研究(n=183)发现,与假手法相比,不良事件风险(相对风险1.24,95%CI 0.85至1.81)或事件持续时间(1.13,95%CI 0.59至2.18)未增加。
  • 一项研究中,数据安全监查委员会判定一例严重不良事件可能与脊柱手法治疗相关;多数观察到的不良事件为肌肉骨骼相关、一过性、轻至中度。

关键数值与推荐

  • 短期疼痛缓解均数差-3.17(95%CI -7.85至1.51),功能SMD -0.25(95%CI -0.41至-0.09),为脊柱手法治疗与推荐疗法比较,中等质量证据。
  • 短期疼痛缓解均数差-7.48(95%CI -11.50至-3.47),功能SMD -0.41(95%CI -0.67至-0.15),为脊柱手法治疗与非推荐疗法比较,高质量证据。
  • 不良事件相对风险1.24(95%CI 0.85至1.81),事件持续时间1.13(95%CI 0.59至2.18),为脊柱手法治疗与假手法比较,n=183。

临床怎么用

  • 临床医生应告知患者脊柱手法治疗相关的潜在不良事件风险。
  • 原文未据此给出其他推荐。

局限性

  • 统计异质性无法解释。
  • 约一半研究评估了不良事件和严重不良事件,但多数研究未明确这些事件如何及是否被系统登记。
  • 假手法脊柱手法治疗证据为低至极低质量,因此这些效应应视为不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the benefits and harms of spinal manipulative therapy (SMT) for the treatment of chronic low back pain. DESIGN: Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: Medline, PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL, Physiotherapy Evidence Database (PEDro), Index to Chiropractic Literature, and trial registries up to 4 May 2018, including reference lists of eligible trials and related reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised controlled trials examining the effect of spinal manipulation or mobilisation in adults (≥18 years) with chronic low back pain with or without referred pain. Studies that exclusively examined sciatica were excluded, as was grey literature. No restrictions were applied to language or setting. REVIEW METHODS: Two reviewers independently selected studies, extracted data, and assessed risk of bias and quality of the evidence. The effect of SMT was compared with recommended therapies, non-recommended therapies, sham (placebo) SMT, and SMT as an adjuvant therapy. Main outcomes were pain and back specific functional status, examined as mean differences and standardised mean differences (SMD), respectively. Outcomes were examined at 1, 6, and 12 months. Quality of evidence was assessed using GRADE. A random effects model was used and statistical heterogeneity explored. RESULTS: 47 randomised controlled trials including a total of 9211 participants were identified, who were on average middle aged (35-60 years). Most trials compared SMT with recommended therapies. Moderate quality evidence suggested that SMT has similar effects to other recommended therapies for short term pain relief (mean difference -3.17, 95% confidence interval -7.85 to 1.51) and a small, clinically better improvement in function (SMD -0.25, 95% confidence interval -0.41 to -0.09). High quality evidence suggested that compared with non-recommended therapies SMT results in small, not clinically better effects for short term pain relief (mean difference -7.48, -11.50 to -3.47) and small to moderate clinically better improvement in function (SMD -0.41, -0.67 to -0.15). In general, these results were similar for the intermediate and long term outcomes as were the effects of SMT as an adjuvant therapy. Evidence for sham SMT was low to very low quality; therefore these effects should be considered uncertain. Statistical heterogeneity could not be explained. About half of the studies examined adverse and serious adverse events, but in most of these it was unclear how and whether these events were registered systematically. Most of the observed adverse events were musculoskeletal related, transient in nature, and of mild to moderate severity. One study with a low risk of selection bias and powered to examine risk (n=183) found no increased risk of an adverse event (relative risk 1.24, 95% confidence interval 0.85 to 1.81) or duration of the event (1.13, 0.59 to 2.18) compared with sham SMT. In one study, the Data Safety Monitoring Board judged one serious adverse event to be possibly related to SMT. CONCLUSION: SMT produces similar effects to recommended therapies for chronic low back pain, whereas SMT seems to be better than non-recommended interventions for improvement in function in the short term. Clinicians should inform their patients of the potential risks of adverse events associated with SMT.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Rubinstein SM, de Zoete A, van Middelkoop M, et al. Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019. PMID: 30867144. doi:10.1136/bmj.l689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。